167 related articles for article (PubMed ID: 3198199)
1. Assessment of exposure and susceptibility to aromatic amine carcinogens.
Kadlubar FF; Talaska G; Lang NP; Benson RW; Roberts DW
IARC Sci Publ; 1988; (89):166-74. PubMed ID: 3198199
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenic aromatic amine metabolism and DNA adduct detection in humans.
Kadlubar FF
Princess Takamatsu Symp; 1990; 21():329-38. PubMed ID: 2134686
[TBL] [Abstract][Full Text] [Related]
6. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens.
Vineis P; Bartsch H; Caporaso N; Harrington AM; Kadlubar FF; Landi MT; Malaveille C; Shields PG; Skipper P; Talaska G
Nature; 1994 May; 369(6476):154-6. PubMed ID: 7909916
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
8. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
9. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
10. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
12. [N-acetylation polymorphism versus differentiation of organic susceptibility to carcinogenic effect of homo- and heterocyclic aromatic amines].
Lutz W; BaraĆski B; Krajewska B
Med Pr; 1994; 45(4):343-9. PubMed ID: 7968503
[TBL] [Abstract][Full Text] [Related]
13. Role of the acetylation polymorphism in determining susceptibility of cultured rabbit hepatocytes to DNA damage by aromatic amines.
McQueen CA; Maslansky CJ; Williams GM
Cancer Res; 1983 Jul; 43(7):3120-3. PubMed ID: 6850620
[TBL] [Abstract][Full Text] [Related]
14. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl.
Roberts DW; Benson RW; Groopman JD; Flammang TJ; Nagle WA; Moss AJ; Kadlubar FF
Cancer Res; 1988 Nov; 48(22):6336-42. PubMed ID: 3180051
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
Tannenbaum SR
Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
[TBL] [Abstract][Full Text] [Related]
17. Molecular dosimetry of aromatic amines in human populations.
Skipper PL; Tannenbaum SR
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
[TBL] [Abstract][Full Text] [Related]
18. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines.
Poupko JM; Radomski T; Santella RM; Radomski JL
J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system.
Oda Y
Mutat Res; 2004 Oct; 554(1-2):399-406. PubMed ID: 15450435
[TBL] [Abstract][Full Text] [Related]
20. DNA adduct levels in congenic rapid and slow acetylator mouse strains following chronic administration of 4-aminobiphenyl.
Flammang TJ; Couch LH; Levy GN; Weber WW; Wise CK
Carcinogenesis; 1992 Oct; 13(10):1887-91. PubMed ID: 1423849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]